
Alan Zajarias MD
Interventional Cardiology
Professor, Internal Medicine, Washington University School of Medicine
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-1291
Fax+1 314-362-4278
Dr. Zajarias is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Zajarias is a cardiologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and St. Louis Children's Hospital. He received his medical degree from Universidad Nacional Autonoma de Mexico and has been in practice 17 years. He also speaks multiple languages, including French and Spanish. He specializes in interventional cardiology and is experienced in valvular heart disease, interventional cardiology, cardiac catheterization, cardiac critical care, and defibrillator implantation. He has more than 80 publications and over 500 citings.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2003 - 2006
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2000 - 2003
Universidad Nacional Autonoma de MexicoClass of 2000
Certifications & Licensure
MO State Medical License 2003 - 2027
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014, 2016-2017
Clinical Trials
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
- PARTNER 3 Trial - Aortic Valve-in-Valve Start of enrollment: 2017 Jan 05
Publications & Presentations
PubMed
- 10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis.Vinod H Thourani, Philipp von Stein, Michael J Mack, Tamim M Nazif, Vasilis Babaliaros
Journal of the American College of Cardiology. 2026-06-16 - Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.Raj R Makkar, Aakriti Gupta, Brian P O'Neill, Christina Lalani, Rahul P Sharma
JAMA. 2026-05-12 - Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.Michael R Hainstock, Gregory Fleming, Dennis Kim, Jamil Aboulhosn, Daniel Levi
Circulation. Cardiovascular Interventions. 2026-05-01
Lectures
- Highlighted Original Research: Valvular Heart Disease and the Year in Review2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Transcatheter vs. Surgical Prosthetic Valve Durability in 20192019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- TAVR: From Valve to Ventricle Evaluation2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Press Mentions
Barnes-Jewish Hospital and Biome Analytics Achieve Breakthrough Results in Reducing Acute Kidney Injury Among Cardiovascular PatientsDecember 10th, 2024
Learn How to Lower Your Risk of Heart DiseaseFebruary 1st, 2019
Assessing TAVR RiskMarch 31st, 2018
Professional Memberships
- Fellow
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









